Four islanders have been jailed for being part of a gang dealing Class A drugs in Guernsey. Ryan Benjamin Gallie, 20, and ...

Jail sentences totalling more than 16 years were imposed yesterday on four people who admitted being concerned in the supply ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

Sitting with about a dozen young Jewish professionals last week, 32-year-old Brooklynite Arielle Krule was passionately leading a discussion about two seemingly unrelated topics that are close to her ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

A serial sex offender, who was ordered to undergo reformative training for a year in 2019 and was sentenced to 16 months’ ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Thanks to funding from Highmark, Valley Health is working to reduce the stigma surrounding mental health by offering Mental ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

the general consensus was that the drug class was an R&D dead end. Merck's exit came after other companies including Pfizer, Eli Lilly and Roche all scrapped CETP development programmes following ...